Download PDF
Synthesis 2006(2): 243-246  
DOI: 10.1055/s-2005-918503
PAPER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of 4-Arylethynyl-2-methyloxazole Derivatives as mGluR5 Antagonists­ for Use in the Treatment of Drug Abuse

Yasuyoshi Iso*, Alan P. Kozikowski
Drug Discovery Program, Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA
Fax: +1(312)9967107; e-Mail: yasuyoshi.isou@shionogi.co.jp;
Further Information

Publication History

Received 6 June 2005
Publication Date:
21 December 2005 (online)

    Permissions and Reprints All articles of this category

Abstract

In structure-activity relationship studies directed toward the use of mGluR5 antagonists in the treatment of drug abuse, we sought a convenient means for gaining access to the oxazole analogues of MTEP. Toward this end, the aldehyde group in 2-meth­yloxazole-4-carboxaldehyde was successfully converted to a trimethylsilylethynyl group via the preparation of a dibromoolefin, conversion to acetylide using NaHMDS and MeLi, and trapping with TMSCl. The resulting versatile intermediate, 2-methyl-4-[(trimethylsilyl)ethynyl]oxazole, was subjected to a modified Sonogashira coupling reaction involving an in situ desilylation reaction with Bu4NF and palladium-catalyzed coupling with an aryl or heteroaryl iodide to give the desired oxazole analogues.

Key words

alkynes - cyclizations - lithiation - palladium - cross-coupling

    References

  • 1 Lima MS. Oliveira MG. Soares BG. Reisser AAP. Farrell M. Addiction  2002,  97:  931 
    CrossrefGoogle Scholar
  • 2 Chiamulera C. Epping-Jordan MP. Zocchi A. Marcon C. Cottiny C. Tacconi S. Corsi M. Orzi F. Conquet F. Nat. Neurosci.  2001,  4:  873 
    CrossrefGoogle Scholar
  • 3 Cosford NDP. Tehrani L. Roppe J. Schweiger E. Smith ND. Anderson J. Bristow L. Brodkin J. Jiang X. McDonald I. Rao S. Washburn M. Varney MA. J. Med. Chem.  2003,  46:  204 
    CrossrefGoogle Scholar
  • 4a Alagille D. Baldwin RM. Roth BL. Wroblewski JT. Grajkowska E. Tamagnan GD. Bioorg. Med. Chem.  2005,  13:  197 
    CrossrefGoogle Scholar
  • 4b Alagille D. Baldwin RM. Roth BL. Wroblewski JT. Grajkowska E. Tamagnan GD. Bioorg. Med. Chem. Lett.  2005,  15:  945 
    CrossrefGoogle Scholar
  • 5a Nicolaou KC. Namoto K. Ritzen A. Ulven T. Shoji M. Li J. D’Amico G. Liotta D. French CT. Wartmann M. Altmann K. Giannakakou P. J. Am. Chem. Soc.  2001,  123:  9313 
    CrossrefGoogle Scholar
  • 5b Grandjean D. Pale P. Chuche J. Tetrahedron Lett.  1994,  35:  3529 
    CrossrefGoogle Scholar
  • 6 Lafontaine JA. Provencal DP. Gardelli C. Leahy JW. J. Org. Chem.  2003,  68:  4215 
    CrossrefPubMedGoogle Scholar
  • 7 Barrish JC. Singh J. Spergel SH. Han WC. Kissick TP. Kronenthal DR. Mueller RH. J. Org. Chem.  1993,  58:  4494 
    CrossrefGoogle Scholar
  • 8 Corey EJ. Fuchs PL. Tetrahedron Lett.  1972,  13:  3769 
    CrossrefGoogle Scholar